MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT06487481 | RECRUITING | PHASE1
32 participants

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2026-05-28
Completion:
2030-12-01
Conditions
  • Adrenocortical Carcinoma (ACC)
  • Recurrent Adrenocortical Carcinoma (ACC)
  • Recurrent Abdominal Adrenocortical Carcinoma (ACC)
  • Carcinoma, Adrenocortical
  • Carcinoma, Adrenal Cortical
Interventions
  • PROCEDURE
  • RADIATION
No Results Yet
NCT06469944 | RECRUITING | PHASE1/PHASE2
160 participants

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-09-20
Completion:
2029-09-12
Conditions
  • Gastroesophageal Junction
  • Gastroesophageal Adenocarcinoma
  • Esophageal Neoplasms
  • Esophageal Cancer
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT06422806 | RECRUITING | PHASE3
365 participants

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-09-11
Completion:
2035-06-30
Conditions
  • Metastatic Dedifferentiated Liposarcoma
  • Metastatic Undifferentiated Pleomorphic Sarcoma
  • Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
  • Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
  • Unresectable Dedifferentiated Liposarcoma
  • Unresectable Undifferentiated Pleomorphic Sarcoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT06406114 | RECRUITING | PHASE2
300 participants

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2025-05-05
Completion:
2028-07-01
Conditions
  • Drug Allergy
  • Cephalosporin Allergy
  • Drug Hypersensitivity
  • Antibiotic Allergy
  • Beta Lactam Adverse Reaction
  • Drug-Induced Anaphylaxis
  • Cephalosporin Reaction
Interventions
  • DRUG
No Results Yet
NCT06352229 | RECRUITING | NA
2327 participants

The Playful Learning in Infancy Program

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2023-06-01
Completion:
2026-11-30
Conditions
  • Parent-Child Relations
  • Infant Development
Interventions
  • BEHAVIORAL
No Results Yet
NCT06327100 | RECRUITING | PHASE1/PHASE2
33 participants

Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-08-01
Completion:
2029-05-01
Conditions
  • Primary Myelofibrosis
  • Post-polycythemia Vera Myelofibrosis
  • Post-Essential Thrombocytosis Myelofibrosis
Interventions
  • DRUG
No Results Yet
NCT06324357 | RECRUITING | PHASE1/PHASE2
768 participants

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-06-03
Completion:
2029-01-08
Conditions
  • Metastatic Breast Cancer
  • Metastatic Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Esophageal Adenocarcinoma
  • Colorectal Cancer
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page